Published in World J Surg on October 20, 2016
Immediate and long-term outcomes of hepatectomy for hepatolithiasis. Surgery (2004) 1.86
Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70
Outcomes of hepatectomy for hepatolithiasis. World J Surg (2007) 1.54
Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. Surgery (2009) 1.34
Outcomes of hepatic resection for hepatolithiasis. Am J Surg (2009) 1.26
Reducing residual and recurrent stones by hepatectomy for hepatolithiasis. J Gastrointest Surg (2007) 1.21
Hepaticojejunostomy for hepatolithiasis: a critical appraisal. World J Gastroenterol (2006) 1.14
Laparoscopic hepatectomy for hepatolithiasis: a feasibility and safety study in 29 patients. Surg Endosc (2007) 1.11
Outcomes of liver resection for intrahepatic stones: a comparative study of unilateral versus bilateral disease. Ann Surg (2012) 1.08
The surgical treatment of isolated left-sided hepatolithiasis: a 22-year experience. Surgery (2000) 1.07
Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis. Hepatogastroenterology (2003) 1.02
Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer (1991) 1.01
Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms. J Hepatobiliary Pancreat Surg (2005) 0.94
Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. J Viral Hepat (2010) 0.92
Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma. Dig Dis Sci (2000) 0.92
Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study. Hepatobiliary Pancreat Dis Int (2011) 0.90
Risk factors for long-term outcomes after initial treatment in hepatolithiasis. J Korean Med Sci (2013) 0.89
What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? J Gastroenterol Hepatol (2002) 0.88
Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis. World J Surg (2009) 0.87
Predictive factors for cholangiocarcinoma associated with hepatolithiasis determined on the basis of Japanese Multicenter study. Hepatol Res (2011) 0.84
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. World J Gastroenterol (2015) 0.84
Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients. World J Surg (2015) 0.84
Endoscopic management of bile duct stones: residual bile duct stones after surgery, cholangitis, and "difficult stones". J Visc Surg (2013) 0.84
Aspirin use and the risk of cholangiocarcinoma. Hepatology (2016) 0.83
Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies. BMC Cancer (2015) 0.81
Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea. World J Gastroenterol (2015) 0.81
Liver Resection for Primary Intrahepatic Stones: Focus on Postoperative Infectious Complications. World J Surg (2016) 0.80
Hepatic resection for bilateral hepatolithiasis: a 20-year experience. ANZ J Surg (2012) 0.79
High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. Surg Endosc (2013) 0.78